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The VIH-46, a modiﬁed version of the VIH-47 developed
in French by Gerbaud based on the SF-36 and the MOS-
HIV, was used as endpoint in a therapeutic educational
program in HIV+. OBJECTIVE: To check the psycho-
metric properties of the VIH-46 in the study population.
The VIH-46 covers 11 Quality of Life (QoL) domains:
Physical Functioning (PF), Role Physical (RP), Bodily
Pain (BP), General Health (GH), Vitality (VT), Social
Functioning (SF), Role Emotional (RE), Mental Health
(MH), Activities of daily Living (ADL), Psychological
Distress (PD), Cognitive Functioning (CF). METHODS:
Three hundred twenty-six patients were analysed for
cross-sectional analyses at baseline (BL) and 242 patients
were analysed over the initial 6-month (M6) period. A
Multitrait Analysis Program (MAP) was used to assess
convergent and divergent item validity. Cronbach°|s f Ñ
measured internal consistency reliability. Values d 0.7
were expected. Floor and ceiling effects were calculated.
The clinical validity was assessed against Karnofski index,
CD4+ count, and virus load. Responsiveness to change
over time was assessed by Effect Sizes (ES) calculation 
in improved and impaired patients according to clinical
change at M6. A value of 0.50 measures moderate
responsiveness. RESULTS: At BL 89.6% patients had no
missing data. All items matched the item-convergent
validity criterion, and all items except two matched the
item-discriminant validity criterion. Internal consistency
reliability was satisfactory. Moderate (20%) to high
(50%) ceiling effects were found in PF, RP, RE, SF, BP,
ADL dimensions. The differences in QoL scores accord-
ing to Karnofski Index, CD4+ level, and virus load, were
limited. The ES were always less than moderate. CON-
CLUSION: in the study population, the impact of com-
pliance on QoL might be too complex to be captured by
the VIH-46. In addition, the importance of ceiling effects
suggests a limitation of the ability of the VIH-46 to detect
improvements.
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OBJECTIVES: This paper reports on the psychometric
properties and further development of the Inﬂuenza Daily
Disruption Questionnaire (IDDQ). Each item of the
IDDQ is answered by indicating degree of agreement
using a ﬁve point response scale (completely agree, agree,
neither agree nor disagree, disagree, completely disagree)
with eight sentences describing the effects of inﬂuenza on
disruption of daily activities. METHODS: The IDDQ was
administered daily in a clinical trial assessing inﬂuenza
treatment. IDDQ psychometric properties were assessed
by examining item response spreads, internal consistency,
and factor analysis. IDDQ scores were examined by age,
gender, and body mass index (BMI) and correlated with
patient-reported physical symptoms (nasal congestion,
sore throat, cough, aches and pains, fatigue, headache,
chills/sweats). Item-response models were also applied.
RESULTS: Factor analysis supported IDDQ unidimen-
sionality; at each day only one component explaining
around 90% of total variance was extracted. IDDQ con-
struct validity was supported by signiﬁcant correlation
coefﬁcients between most IDDQ items including the
IDDQ total score and all seven symptoms, in terms of
both day-to-day and AUC scores. While half of the items
had well-distributed response ranges, for others patients
used mainly one end of the scale. These same items were
the least internally consistent and on Rasch analysis most
likely to have reversed thresholds related to the mid-point
response “neither agree nor disagree” (individual item ﬁt
p < 0.01). In general, there was only a low probability of
subjects choosing the mid-point response option. The
mid-point response was therefore dropped in a revised
IDDQ, which has a 4-point response scale (completely
agree, agree, disagree, completely disagree). CONCLU-
SIONS: The revised IDDQ with a four-point response
scale has acceptable psychometric properties. Further use
of the revised IDDQ is recommended, especially in com-
munity-based epidemiological studies that may capture a
broader spectrum of severity of inﬂuenza that usually seen
in clinical studies.
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OBJECTIVES: The Recurrent Genital Herpes Quality of
Life questionnaire (RGHQoL) is a needs-based quality of
life (QoL) instrument speciﬁc to recurrent genital herpes
(RGH), with excellent psychometric properties. However,
it cannot be used to directly derive utility. Existing utility
instruments cover symptoms/functioning, rather than
QoL, raising concerns over their relevance for RGH and
